Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in pfizer

BioNTech says no infomation on vaccination start in Germany

BioNTech says no infomation on vaccination start in Germany

Read More

Vaccine alliance raises $2 billion to buy COVID shots for poor nations

Another $5 billion will also be needed in 2021 to procure COVID-19 vaccine doses as they come through development and are approved by regulators

Read More

Medicago's COVID-19 Vaccine Triggers Immune Response In Early-Stage Trial

Medicago is Canada's most advanced domestic COVID-19 vaccine project, but lags larger, global rivals such as Pfizer, AstraZeneca Plc and Johnson & Johnson which have begun late-stage trials.

Read More

Analysis: Vaccine news may weaken need for US stimulus, but help still needed - investors

Democrats have pushed for a $2 trillion package, with support for state and local governments that are facing steep layoffs, but Senate Majority Leader Mitch McConnell has pushed back, arguing Congress should enact a smaller coronavirus stimulus package highly targeted at the pandemic's effects.

Read More

Pfizer Vaccine Trial Success Signals Breakthrough In Pandemic Battle

Shares of other vaccine developers in the final stage of testing also rose with Johnson & Johnson up nearly 4% and Moderna Inc, whose vaccine uses a similar technology as the Pfizer shot, up more than 8%.

Read More

End of fight against Covid-19 still months away, says Biden on Pfizer's vaccine progress

End of fight against Covid-19 still months away, says Biden on Pfizer's vaccine progress

Read More

Pfizer says its coronavirus vaccine more than 90 pc effective in first analysis

Pfizer says its coronavirus vaccine more than 90 pc effective in first analysis

Read More

Australia signs COVID-19 vaccine deals with Novavax, Pfizer

Australia signs COVID-19 vaccine deals with Novavax, Pfizer

Read More

Pfizer Q2 Net Profit Declines 15% At To 131.37 Cr

The company had posted a net profit of Rs 154.25 crore for the corresponding period of the previous fiscal

Read More

J&J Plans To Test Its COVID-19 Vaccine In Ages 12-18 Soon

J&J started testing the vaccine in adults in a 60,000-volunteer Phase III study in late September. It had to pause the trial earlier this month because of a serious medical event in one participant. The study resumed last week.

Read More

Pfizer Says Earliest US Filing For COVID-19 Vaccine Would Be Late November

Pfizer's shares were up 3.5% in afternoon trading, while BioNTech's U.S.-listed shares were up 3.9%. Moderna shares fell 1.5%.

Read More

New Zealand Signs Deal With Pfizer, Biontech For COVID-19 Vaccine

The Pfizer-BioNTech vaccine is one of the leading candidates in the race to be the first to get regulatory approval in the United States and Europe.

Read More

EU Reviewing Pfizer-Biontech COVID-19 Vaccine In Real Time

Pfizer and BioNTech said in a joint statement the start of the review is based on data from laboratory and animal testing, as well as early testing on humans

Read More

BioNTech Wins $445 Million German Grant For COVID-19 Vaccine

BioNTech and Pfizer are already testing their most promising vaccine candidate in late-stage trials and have started recruiting patients in the United States, Brazil, Argentina and Europe.

Read More

Global Scenario For Covid-19 Vaccines

This is a brief review comparing the four most globally popular COVID-19 vaccines in the making and the ways in which it could contribute to global health in the future ahead.

Read More